SCOPUS 정보 검색 플랫폼

Australasian Journal of Dermatology

Volumn 45, Issue 3, 2004, Pages 193-195

Use of infliximab in the treatment of psoriasis [1]

(2) Lee, Michael R a Cooper, Alan J a

a ROYAL NORTH SHORE HOSPITAL (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALEFACEPT; CALCIPOTRIOL; CORTICOSTEROID; CYCLOSPORIN; DITHRANOL; EMOLLIENT AGENT; ETRETIN; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARACETAMOL; PROMETHAZINE; SALICYLIC ACID; TAR;

ADULT; CASE REPORT; CLINICAL FEATURE; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG RESPONSE; FEMALE; HUMAN; HYPERTENSION; LETTER; LIVER BIOPSY; LIVER CELL DAMAGE; MALE; PHYSICAL EXAMINATION; PSORIASIS; PSORIATIC ARTHRITIS; PUVA; SYMPTOM; TREATMENT FAILURE;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; CYCLOSPORINE; DERMATOLOGIC AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, INTRAVENOUS; MALE; METHOTREXATE; MIDDLE AGED; PSORIASIS; REMISSION INDUCTION; TIME FACTORS;

EID: 4043147119 PISSN: 00048380 EISSN: None Source Type: Journal
DOI: 10.1111/j.1440-0960.2004.00090.x Document Type: Letter

Times cited : (4)

References (6)

1
- 0038017157
- Treatment of severe recalcitrant plaque psoriasis with single-dose intravenous tumour necrosis factor-alpha antibody (infliximab)
- Chan JJ, Gebauer K. Treatment of severe recalcitrant plaque psoriasis with single-dose intravenous tumour necrosis factor-alpha antibody (infliximab). Australas. J. Dermatol. 2003; 44: 116-20.
- (2003) Australas. J. Dermatol. , vol.44 , pp. 116-120
- Chan, J.J.¹ Gebauer, K.²

2
- 0035832515
- Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: A randomized trial
- Chaudhari U, Romano P, Mulcahy LD, Dooley LT, Baker DG, Gottlieb AB. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomized trial. Lancet 2001; 557: 1842-7.
- (2001) Lancet , vol.557 , pp. 1842-1847
- Chaudhari, U.¹ Romano, P.² Mulcahy, L.D.³ Dooley, L.T.⁴ Baker, D.G.⁵ Gottlieb, A.B.⁶

3
- 0036621139
- Treatment of psoriasis with the chimeric monoclonal antibody against tumor necrosis factor α, infliximab
- Schopf RE, Aust H, Knop J. Treatment of psoriasis with the chimeric monoclonal antibody against tumor necrosis factor α, infliximab. J. Am. Acad. Dermatol. 2002; 46: 886-91.
- (2002) J. Am. Acad. Dermatol. , vol.46 , pp. 886-891
- Schopf, R.E.¹ Aust, H.² Knop, J.³

4
- 0036715313
- Cutaneous drug eruption to infliximab: Report of 4 cases with an interface dermatitis pattern
- Vergara G, Silvestre JF, Betlloch I, Vela P, Albares MP, Pascual JC. Cutaneous drug eruption to infliximab: Report of 4 cases with an interface dermatitis pattern. Arch. Dermatol. 2001; 138: 1258-9.
- (2001) Arch. Dermatol. , vol.138 , pp. 1258-1259
- Vergara, G.¹ Silvestre, J.F.² Betlloch, I.³ Vela, P.⁴ Albares, M.P.⁵ Pascual, J.C.⁶

5
- 0035846326
- Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralising agent
- Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralising agent. N. Engl. J. Med. 2001; 345: 1098-104.
- (2001) N. Engl. J. Med. , vol.345 , pp. 1098-1104
- Keane, J.¹ Gershon, S.² Wise, R.P.³ Mirabile-Levens, E.⁴ Kasznica, J.⁵ Schwieterman, W.D.⁶ Siegel, J.N.⁷ Braun, M.M.⁸

6
- 0037148920
- Tuberculosis and treatment with infliximab
- Lim WS, Powell RJ, Johnston ID. Tuberculosis and treatment with infliximab. N. Engl. J. Med. 2002; 346: 623-6.
- (2002) N. Engl. J. Med. , vol.346 , pp. 623-626
- Lim, W.S.¹ Powell, R.J.² Johnston, I.D.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.